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Abstract
Background: Dopamine in prefrontal cortex (PFC) modulates core cognitive processes, notably working memory
and executive control. Dopamine regulating genes and polymorphisms affecting PFC - including Catechol-O-
Methyltransferase (COMT) Val158Met - are crucial to understanding the molecular genetics of cognitive function
and dysfunction. A mechanistic account of the COMT Val158Met effect associates the Met allele with increased
tonic dopamine transmission underlying maintenance of relevant information, and the Val allele with increased
phasic dopamine transmission underlying the flexibility of updating new information. Thus, consistent with some
earlier work, we predicted that Val carriers would display poorer performance when the maintenance component
was taxed, while Met carriers would be less efficient when rapid updating was required.
Methods: Using a Stroop task that manipulated level of required cognitive stability and flexibility, we examined
reaction time performance of patients with schizophrenia (n = 67) and healthy controls (n = 186) genotyped for
the Val/Met variation.
Results: In both groups we found a Met advantage for tasks requiring cognitive stability, but no COMT effect
when a moderate level of cognitive flexibility was required, or when a conflict cost measure was calculated.
Conclusions: Our results do not support a simple stability/flexibility model of dopamine COMT Val/Met effects and
suggest a somewhat different conceptualization and experimental operationalization of these cognitive
components.
Background
Dopamine level in prefrontal cortex (PFC) and stria-
tum modulates core cognitive processes by tuning neu-
ronal and circuit responses [1,2]. Understanding genes
that regulate dopamine in PFC - such as catechol-O-
methyltransferase (COMT) gene on chromosome
22q11 - may help to unravel the complex neurobiolo-
gical processes that underlie cognitive function and
dysfunction in health and illness. A COMT poly-
morphism, Val158Met, plays a central role in cortical
dopamine degradation, with the Val allele associated
with greater COMT enzyme activity, greater dopamine
degradation and less synaptic dopamine than the Met
allele [3,4]. Val158Met has been linked to prefrontally
mediated cognition (e.g., executive function and work-
ing memory - [5-7] - and attentional control - [8,9];
but see [10]). In particular, considerable evidence sug-
gests that Met alleles are associated with more efficient
patterns of prefrontal cortical activation and superior
cognitive performance. This pattern has been observed
in schizophrenia patients [5], and in most of the litera-
ture, COMT effects are independent of psychiatric
diagnosis or risk status, suggesting that genotype mod-
ulates typical as well as impaired prefrontal cognition
[5]. Given the complexity of clinical diagnosis, cogni-
tive performance has been proposed as an intermediate
phenotype for investigation of schizophrenia [11].
Much early work linking genes to neurobiology has
relied on simple biological models and traditional neurop-
sychological measures (e.g., the Wisconsin Card Sorting
Test). More recent investigations have proposed more
detailed models and sophisticated psychometric assays to
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any medium, provided the original work is properly cited.parse and segregate underlying cognitive processes, or at
least restrict the processes by which one succeeds or fails
on a task. For example, one biologically plausible account
of the effects of Val158Met on cognition builds on emer-
ging ideas about the roles of tonic and phasic dopamine in
cognitive processing. This theory proposes that tonic
stimulation of cortical D1 receptors stabilizes and main-
tains relevant information, while phasic stimulation of
striatal D2 receptors underlies “cognitive flexibility”, such
as updating and manipulating information [2,12]. Extend-
ing the theory to Val158Met, it has been proposed that
the Met allele is associated with increased tonic dopamine
transmission, while the Val allele is associated with
increased phasic dopamine transmission. Thus Met car-
riers would be expected to display greater efficiency and
better performance on the elements of working memory
and executive tasks that require stable maintenance of
information, and Val carriers would be more efficient
when cognitive flexibility is required, such as during rapid
updating or task switching [13].
To test this hypothesis, one group of investigators
used a response shifting paradigm, the Competing Pro-
grams Task, in a small sample of patients with schizo-
phrenia and schizoaffective disorder (n = 26) [14]. The
task required responding to an imitation rule (e.g., two
cues followed by two button presses) during blocks 1
and 3 and a reversal rule (one cue followed by two but-
ton presses or two cues followed by one button press)
during blocks 2 and 4. Participants transitioned between
conditions and the rules changed after either a maxi-
mum of 20 trials, or after 8 consecutive correct
responses were produced by the participant. Met homo-
zygotes (n = 8) generated significantly faster responses
than Val homozygotes (n = 6), were significantly more
accurate in the imitation condition, and required signifi-
cantly fewer trials-to-criterion for the imitation blocks.
The authors interpreted these findings as support for an
association between greater cognitive stability and the
Met allele. Participants with Val alleles performed better
on a derived measure intended to index cognitive flex-
ibility [14].
Although the investigators reported their findings as
consistent with the tonic/ph a s i cd o p a m i n eh y p o t h e s i s ,
this interpretation is not clear cut, for several reasons.
As an initial matter, the Competing Programs Task may
be better understood as a paradigm requiring different
levels of cognitive control or conflict processing than as
a task alternately requiring stable and flexible cognitive
processing. Essentially, the imitation condition requires
participants to emit a relatively intuitive response, sug-
gested by the stimuli, while the reversal condition
requires that participants resist the intuitive response
and produce an exactly counter-intuitive response. In
this regard the task presented in [14] is reminiscent of
the classic Stroop paradigm, in which emphasis is first
placed on relatively automatic word reading, and then
on resisting automatic word reading in order to name
incongruent colors in later trials. If the Competing
Programs Task is better interpreted as a cognitive con-
trol or conflict processing paradigm, requiring focused
response inhibition rather than flexible, fluid updating,
it maps quite differently onto the tonic/phasic dopamine
hypothesis. Recently, another study addressed this
hypothesis through an analysis of the Attention Network
Task (a version of the Flanker paradigm)[15]. This
report refers specifically to the analysis in [14], but here
the investigators framed this question as whether Val
carriers might have an advantage relative to Met carriers
in conflict processing rather than cognitive flexibility.
Importantly, in these studies, the putative Val advan-
tage is open to question for parallel reasons. Although
the paradigms (Competing Programs vs. Attention Net-
work Task) and parameters (accuracy vs RT) are differ-
ent, both studies calculate a “switching cost” that relates
performance on the simpler congruent condition to per-
formance on the more difficult conflict condition. In
principle, the “Val advantage” on these cost indexes
c o u l db ee n t i r e l ya c c o u n t e df o rb yt h el o s so fas i g n i f i -
cant Met advantage in the simpler processing condition,
rather than any frank Val advantage. For example, [14]
reported a Met allele trials-to-criterion advantage for
the simpler, imitation blocks of their task, but no Met
or Val allele advantage for the switching blocks, indicat-
ing the loss of a Met advantage, but not the emergence
of a Val advantage.
A further point is that the broad literature addressing
the relationship of Val158Met with cognition is difficult
to reconcile with a sharp genotype-based distinction
between stable and flexible cognitive processing. Gener-
ally, this literature shows a Met advantage across various
tasks that seem to mix demands for stable and flexible
cognitive processing. For example, several reports have
documented a Met advantage on a spatial working mem-
ory task that requires both maintenance of information
and also continuous updating of the contents of working
memory (e.g., [16]), on a numerical computation task
that required performing subtraction then making a size
comparison [17], and, in children, on a dots-mixed task
requiring working memory and inhibition [18]). Addi-
tionally, the Met allele has been specifically associated
with speeded low-level lexical access (on a letter compar-
ison task, but not on simple pattern comparison [19]),
and with a speed advantage for response times [20].
Finally, we are not aware of consistent findings of Val
allele advantages in any reported cognitive tasks.
To help clarify these issues, we conducted an analysis
of Val158Met effects roughly parallel to [14], using the
more familiar Stroop paradigm, in a large sample of
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We (i) challenged participants by utilizing a cognitive
assay that manipulated the level of required cognitive
control within the same task, and (ii) examined whether
Met carriers would display a performance advantage
only when the cognitive control requirement was low,
and Val carriers would perform better when the demand
for cognitive control was increased.
Methods
Participants
Sixty-seven patients with a DSM-IV diagnosis of schizo-
phrenia or schizoaffective disorder and 168 healthy
volunteers participated (see Table 1). Our protocol was
approved by an Institutional Review Board, and all parti-
cipants gave written informed consent, in accordance
with the Helsinki Declaration.
Design and procedure
As part of the NIMH Sibling Study [5], all participants
completed a neuropsychological test battery to determine
cognitive functioning. Additionally, a behavioral Stroop
task was presented via a computer monitor that required
rapid and accurate responding by pressing buttons
labeled “red” (right button) or “green” (left button) to the
words “green” and “red” that appeared one at a time. The
level of task demands was manipulated by presenting
either congruent or incongruent test items (e.g., “green”
w r i t t e ni ng r e e ni n k ,v e r s u s“green” w r i t t e ni nr e di n k ) ,
and by either keeping the cue - and thus task - demands
constant during portions of the task (i.e., responding to
the word or responding to ink color) or switching the
cue randomly in other portions, and thus introducing fre-
quently shifting task demands.
Stimuli remained on the screen until a button was
pushed, or for a maximum of 3000 msecs. Median reac-
tion times (RTs) for correct trials were computed to
control for outliers. Reaction time data was used for this
analysis, as even in the most difficult switching condi-
tion participants were fairly accurate: patients’ average =
89.75%, healthy volunteers’ average = 94.04%. COMT
Val158Met (rs4680) genotyping was performed on DNA
obtained from B lymphoblast cell lines using the
Taqman 5′-exonuclease assay as described previously
[3]. There were no significant genotype differences by
age, gender, or WRAT-IQ in patients or healthy volun-
teers (All F’s < 2.13, all p’s > 0.13).
Results
First, given the large element of automaticity in reading,
and the simple but rapid mapping required between lex-
ical-semantic aspects of the stimuli and response, we
predicted the Met allele would be associated with super-
ior performance when the demand for cognitive flexibil-
i t ya n d / o rc o n t r o lw a sl o w ,n a m e l ys i m p l er e a d i n go f
the words “green” and “red” (in black ink).
As expected, patients’ performance was overall slower
than controls (F(1,251) = 27.93, p < .0001), but qualita-
tively similar: In patients, there was a Met allele RT advan-
tage (F(2,64) = 5.87, p = .004; effect size (Cohen’s f) = .38
[21]) (see Figure 1). This Met advantage was also asso-
ciated with general speed in participants with schizophre-
nia (F(2,63) = 4.77, p = 0.01; effect size (Cohen’s f) = .33)
on a composite of speeded neuropsychological tasks
(Trails-A, Trails-B, and Digit-Symbol task from the
WAIS-R, see [22] for details of composite speed measure),
and is consistent in magnitude with a previous report of a
Met allele advantage in patients with schizophrenia on
these three neuropsychological tasks [23]. In our controls
there was a Met allele RT advantage (F(2,183) = 3.00,
p = .05; effect size (Cohen’s f)=. 1 4 )b u tt h i sw a sn o t
related to the general speed composite. Thus, as predicted,
there was a Met advantage on the speed of response dur-
ing a relatively undemanding facet of this task.
Second, we investigated whether the Met allele advan-
tage would disappear once the task demands included a
high control/flexibility component, as found with the
reversal condition in [14]. Within our reversal condition,
which required responding to the color (red or green) of
the opposite word (red or green), there was no effect of
genotype on reaction time among patients (F(2,64) =
2.31, p = 0.11)(although the Val/Val patient group’s
average reaction time was slower than the Val/Met’s,
consistent with an overall Met advantage), or controls
(F(2,183) = 0.7, p = 0.50) (see Figure 2).
Third, we investigated whether our derived measure of
“conflict cost”- calculated as the percent increase in reac-
tion time between the Neutral Color trials and the cued
Incongruent Color trials - would reveal a Val allele
advantage, analogously to the report of [14]. We found
no effect of genotype on this measure among our patients
(F(2,64) = 1.48, p = 0.23) or controls (F(2,183) = 1.22, p =
0.29) (see Figure 3).
Discussion
We applied COMT Val158Met genotype to a familiar
cognitive assay in order to re-examine the explanatory
Table 1 Age, gender, IQ and COMT genotype distribution
of patients and controls
Variable Patients (n = 67) Controls(n = 186)
Age (years) - mean, SD 34, 9.89 36, 10.88
Females/Males 14/53 95/91
WAIS-R IQ *- mean, range 93, 70-113 108, 87-129
WRAT-R IQ* - mean, range 103, 73-120 109, 81-127
Val/Val, Val/Met, Met/Met 17, 31, 19 43, 97, 46
*p < .05
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nitive stability and flexibility, task characteristics that are
inherent - and likely confounded - in many measures of
working memory and executive function. We attempted
to replicate the findings of [14], that Met carriers display
a performance advantage when the simpler maintenance
component is taxed, while Val carriers are more efficient
when more flexible processing is required. Our results
were inconsistent with this hypothesis. Although our
experimental operationalization of these cognitive com-
ponents contributes to the growing literature on the
superiority of Met alleles in working memory tasks, we
did not uncover any frank advantage of the Val alleles
in any condition. Our analyses of ‘switching costs’,t h e
parameter that has been used to operationalize ‘flexibil-
ity’ in earlier examinations of this hypothesis, were non-
significant. Additionally, this pattern, although non-sig-
nificant, was in the direction we would expect if all that
were occurring was a loss of the Met advantage. Specifi-
cally, it appears that the Met/Mets and Val/Mets have
higher ‘costs’ on this task, without any evidence of a
Val/Val advantage, and this result is similar (as far as we
can tell) to that of earlier reports.
Furthermore, we would argue that previous operatio-
nalizations of the hypothesis have strayed from its initial
conception insofar as they have relied on versions of the
Figure 1 Average reaction times (msecs) of reading and responding to the words “red” and “green” written in black ink in patients and
controls as a function of COMT genotype (24 trials). Error bars represent standard error. a = vs Val/Met. b = vs Met/Met. *p < .055. **p < .01
Figure 2 Average reaction times (msecs) in patients and controls as a function of COMT genotype of naming the ink color (red or
green) of the alternate word (red or green) (12 trials total). Error bars represent standard error. a = vs Val/Met. *p < .05
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in the context of the Competing Programs Task (14),
the Attention Network Test (15), or the Stroop para-
digm analyzed here, these parameters measure effortful
cognitive control or conflict processing rather than the
fluid, flexible cognitive processing that appears to be
anticipated by the tonic/phasic dopamine model, and
therefore do not squarely address the effects of dopa-
mine activity on flexibility. Even with these differing
interpretations, this study and most others have failed to
find a consistent Val advantage for any tasks or condi-
tions. This study adds to the literature of a Met advan-
tage for tasks demanding cognitive stability, and
acknowledges the need for a more refined model of the
relationship between dopamine physiology and
cognition.
Although the Tonic/Phasic Dopamine hypothesis
yields an elegant model, a convincing demonstration of
a Val advantage has yet to be reported. Nolan et al.
attempted to capture the basics of the model, however,
the task examined in that study likely confounded cog-
nitive control with cognitive flexibility. Even with a simi-
lar operationalization we failed to replicate the findings
of [14], and our results are more consistent with the
broader literature indicating a general Met allele advan-
tage and no frank Val advantages. Beyond psychometric
differences, this story is likely to be magnitudes more
complex with haplotype, gene-gene interaction, and
gene-environment interaction effects on this behavioral
phenotype. Indeed, our study underscores how much
remains to be discovered concerning the role of func-
tional polymorphisms in cognitive function and the
need for further research in order to fine-tune useful
clinical intermediate phenotypes that affect high-level
information processing.
Limitations
Although relatively large for such a study, it would be
b e n e f i c i a li nt h ef u t u r et oe m p l o yab i g g e rs a m p l es o
that the role of other variables (e.g., gender) can be
examined. This would afford sufficient power to under-
take a meaningful and sophisticated analysis of the effect
of COMT Val/Met on trial-by-trial performance so as to
determine switching costs between individual trials, spe-
cifically between congruent and incongruent trials.
Conclusions
Our data do not support a simple tonic/phasic model of
COMT Val/Met effects. We found a Met allele advan-
tage for tasks requiring cognitive stability, but no frank
Val advantage for tasks of cognitive stability or cognitive
flexibility.
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